Story by John Lauerman • Yesterday 3:21 PM (Bloomberg) — Merck & Co.’s Covid-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen’s genetic code. BARI, ITALY – JANUARY 11: Doctor holds in her hands the...
